Fetal & Neonatal Care Device Sector to Reach around USD 10.791 Bn by 2023, States IQ4I in Its Discounted Report Available at MarketPublishers.com
14 Dec 2017 • by Natalie Aster
LONDON – Worldwide, the fetal and neonatal care device market is poised to reach around USD 10.791 billion by 2023, at a single-digit CAGR.
Amid the fetal products, ultrasound devices grabbed the biggest share as of 2016 owing to the development of 3D/4D imaging solutions. The fetal MRI segment posts the most rapid growth owing to the development of miniaturised MRI and product pipeline which are yet to be launched. Neonatal care devices grabbed the lion’s share due to technological advances in the treatment of a range of newborn diseases and associated infections. The infant warmers segment captured the dominant share as of 2016 due to technological advancements and is also projected to keep on seeing a strong CAGR to 2023.
Based on end-user sector, hospital segment captured the largest share as of 2016 and is anticipated to see a healthy CAGR to 2023 owing to the presence of complex equipment at one place. The private clinic segment is the most rapid evolving segment and is set to observe a robust CAGR over the forecast period.
The North America region dominates the world fetal and neonatal care device market, with Europe tagging behind. The regional market is driven by a steep upsurge in premature infant population, technology advances, people’s awareness about treatment modalities, a hike in neonatal diseases, and favourable government policies, among others.
The market is consolidated, with major players accounting for 72% of the total market. GE Healthcare, Dragerwerk AG & Co. KGaA, Philips N.V., Medtronic PLC, Siemens AG, Natus Medical Incorporated, Atom medical corporation, Cooper Companies, Inc, Fisher & Paykal, and Masimo Corporation, amid others, are some of the top market players.
Discounted report “Fetal and Neonatal Care Devices Global Market – Forecast To 2023” elaborated by IQ4I Research & Consultancy provides a comprehensive, unprejudiced assessment of the market on a global level.
The study provides granular market classification by product, end-user sector, and includes a regional market evaluation. It gives insights into key factors impacting the market covering market drivers and limiters, opportunities and threats. The report also provides an analysis of the reimbursement scenario, patent analysis, upcoming launches of technologies and products, clinical trial data, regulatory affairs, mayor players’ market shares, fetal and neonatal care device number of units by region, etc. The study canvasses the competitive scenario and profiles the top 13 companies. Detailed forecasts of the market are also provided.
More discounted and new reports by the publisher can be found in IQ4I Research & Consultancy catalogue at MarketPublishers.com.